A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29
S P H Alexander(University of Nottingham), Michael Spedding(Ta Solutions (China)), Elena Faccenda(University of Edinburgh), Christopher Southan(University of Edinburgh), Francesca Levi‐Schaffer(Hebrew University of Jerusalem), Adam J Pawson(University of Edinburgh), Simon D Harding(Neurosciences Institute), Jane F Armstrong(Neurosciences Institute), Jamie A. Davies(University of Edinburgh), Anthony P. Davenport(University of Cambridge), Janet J. Maguire(University of Cambridge)
Cited by 73
Related Papers
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
|Nucleic Acids Research|2017|1.7k
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
|Nucleic Acids Research|2015|1k
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
|Nucleic Acids Research|2013|860
The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors
|British Journal of Pharmacology|2015|849
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712